• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一般人群 EORTC QLQ-C30 量表的常模值,按年龄、性别和健康状况分组,针对法国一般人群。

General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.

机构信息

Health Outcomes Research Unit, University Hospital of Psychiatry II, Medical University of Innsbruck, Innrain 43, Innsbruck, 6020, Austria.

Psychological Diagnostics and Intervention, Catholic University of Eichstätt-Ingolstadt, Eichstätt, Germany.

出版信息

J Patient Rep Outcomes. 2024 May 2;8(1):48. doi: 10.1186/s41687-024-00719-7.

DOI:10.1186/s41687-024-00719-7
PMID:38695992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11065800/
Abstract

BACKGROUND

General population normative values for the widely used health-related quality of life (HRQoL) measure EORTC QLQ-C30 support the interpretation of trial results and HRQoL of patients in clinical practice. Here, we provide sex-, age- and health condition-specific normative values for the EORTC QLQ-C30 in the French general population.

METHODS

French general population data was collected in an international EORTC project. Online panels with quota samples were used to recruit sex and age groups. Number and type of comorbidities were assessed. Descriptive statistics were used to calculate general population values for each QLQ-C30 scale, separately for sex, age, and presence of one- and more chronic health conditions. A multivariate linear regression model has been developed to allow estimating the effect of sex, age, and the presence for one- and more chronic health conditions on EORTC QLQ-C30 scores. Data was weighted according to United Nation statistics adjusting for the proportion of sex and age groups.

RESULTS

In total, 1001 French respondents were included in our analyses. The weighted mean age was 47.9 years, 514 (51.3%) participants were women, and 497 (52.2%) participants reported at least one health condition. Men reported statistically significant better scores for Emotional Functioning (+9.6 points, p = 0.006) and Fatigue (-7.8 point; p = 0.04); women reported better profiles for Role Functioning (+8.7 points; p = 0.008) and Financial Difficulty (-7.8 points, p = 0.011). According to the regression model, the sex effect was statistically significant in eight scales; the effect of increasing age had a statistically significant effect on seven of the 15 EORTC QLQ-C30 scales. The sex- and age effect varied in its direction across the various scales. The presence of health conditions showed a strong negative effect on all scales.

CONCLUSION

This is the first publication of detailed French normative values for the EORTC QLQ-C30. It aims to support the interpretation of HRQoL profiles in French cancer populations. The strong impact of health conditions on QLQ-C30 scores highlights the importance of considering the impact of comorbidities in cancer patients when interpreting HRQoL data.

摘要

背景

广泛使用的健康相关生活质量(HRQoL)量表 EORTC QLQ-C30 的一般人群参考值支持对临床试验结果和临床实践中患者的 HRQoL 的解释。在这里,我们提供了法国一般人群中 EORTC QLQ-C30 的性别、年龄和健康状况特定的参考值。

方法

从一个国际 EORTC 项目中收集了法国一般人群的数据。使用具有配额样本的在线小组招募了不同性别和年龄组的参与者。评估了合并症的数量和类型。使用描述性统计数据分别计算了每个 QLQ-C30 量表的一般人群值,按性别、年龄以及存在一种或多种慢性健康状况进行了划分。开发了一个多元线性回归模型,以允许估计性别、年龄以及存在一种或多种慢性健康状况对 EORTC QLQ-C30 评分的影响。根据联合国统计数据,根据性别和年龄组的比例对数据进行了加权调整。

结果

共有 1001 名法国受访者纳入了我们的分析。加权平均年龄为 47.9 岁,514 名(51.3%)参与者为女性,497 名(52.2%)参与者报告至少有一种健康状况。男性在情感功能(+9.6 分,p=0.006)和疲劳(-7.8 分,p=0.04)方面的报告得分明显更好;女性在角色功能(+8.7 分,p=0.008)和经济困难(-7.8 分,p=0.011)方面的报告得分更好。根据回归模型,性别效应在 8 个量表中具有统计学意义;年龄增加的效应在 15 个 EORTC QLQ-C30 量表中的 7 个量表中具有统计学意义。性别的年龄效应在不同的量表中方向不同。健康状况的存在对所有量表都有强烈的负面影响。

结论

这是第一个关于 EORTC QLQ-C30 的详细法国参考值的出版物。它旨在支持对法国癌症人群 HRQoL 特征的解释。健康状况对 QLQ-C30 评分的强烈影响突出了在解释 HRQoL 数据时考虑合并症对癌症患者的影响的重要性。

相似文献

1
General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.一般人群 EORTC QLQ-C30 量表的常模值,按年龄、性别和健康状况分组,针对法国一般人群。
J Patient Rep Outcomes. 2024 May 2;8(1):48. doi: 10.1186/s41687-024-00719-7.
2
EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.EORTC QLQ-C30 普通人群意大利人群的性别、年龄和健康状况的常模数据:对 1036 个人的分析。
BMC Public Health. 2022 May 24;22(1):1040. doi: 10.1186/s12889-022-13211-y.
3
Development and validation of crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status/quality of life scales and their corresponding PROMIS scales.欧洲癌症研究与治疗组织(EORTC)QLQ - C30身体、角色、社会和情感功能、疲劳及总体健康状况/生活质量量表与相应的患者报告结果测量信息系统(PROMIS)量表之间的转换关系的建立与验证。
J Clin Epidemiol. 2025 May 29;184:111853. doi: 10.1016/j.jclinepi.2025.111853.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
A systematic review of patient-reported outcome measures for advanced skin cancer patients.晚期皮肤癌患者报告结局测量的系统评价。
Arch Dermatol Res. 2023 Aug;315(6):1473-1480. doi: 10.1007/s00403-022-02479-0. Epub 2022 Dec 5.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Yoga for fatigue in people with cancer.瑜伽对癌症患者疲劳的作用
Cochrane Database Syst Rev. 2025 May 27;5(5):CD015520. doi: 10.1002/14651858.CD015520.
8
Home-based multidimensional survivorship programmes for breast cancer survivors.针对乳腺癌幸存者的居家多维康复计划。
Cochrane Database Syst Rev. 2017 Aug 24;8(8):CD011152. doi: 10.1002/14651858.CD011152.pub2.
9
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
10
Chlorhexidine mouthrinse as an adjunctive treatment for gingival health.洗必泰漱口水作为牙龈健康的辅助治疗方法。
Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD008676. doi: 10.1002/14651858.CD008676.pub2.

引用本文的文献

1
The current use and application of thresholds for clinical importance of the EORTC QLQ-C30, the EORTC CAT core and the EORTC QLQ-C15-PAL- a systematic scoping review.欧洲癌症研究与治疗组织QLQ-C30、欧洲癌症研究与治疗组织CAT核心量表以及欧洲癌症研究与治疗组织QLQ-C15-PAL临床重要性阈值的当前使用与应用——一项系统的范围综述
Health Qual Life Outcomes. 2025 Jun 3;23(1):55. doi: 10.1186/s12955-025-02387-7.
2
Cancer-Specificity of Sex Differences and Sex-Specific Impact of Sociodemographic Characteristics in Cancer Patients' Health-Related Quality of Life: A Cross-Sectional Study.癌症患者健康相关生活质量中性别差异的癌症特异性及社会人口学特征的性别特异性影响:一项横断面研究
Psychooncology. 2025 May;34(5):e70170. doi: 10.1002/pon.70170.
3
Factors influencing quality of life in patients with a colostomy due to rectal cancer: A retrospective cohort study with multivariate and subgroup analyses.影响直肠癌结肠造口患者生活质量的因素:一项多变量和亚组分析的回顾性队列研究。
Oncol Lett. 2025 Apr 11;29(6):295. doi: 10.3892/ol.2025.15041. eCollection 2025 Jun.

本文引用的文献

1
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).TAVAREC 试验随机Ⅱ期研究结果:替莫唑胺联合或不联合贝伐珠单抗治疗 1p/19q 未缺失的首次复发的世界卫生组织(WHO)2 级和 3 级胶质瘤(欧洲癌症研究与治疗组织 26091 试验)患者的健康相关生活质量。
Eur J Cancer. 2023 Sep;190:112946. doi: 10.1016/j.ejca.2023.112946. Epub 2023 Jun 19.
2
EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.EORTC QLQ-C30 普通人群意大利人群的性别、年龄和健康状况的常模数据:对 1036 个人的分析。
BMC Public Health. 2022 May 24;22(1):1040. doi: 10.1186/s12889-022-13211-y.
3
General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.根据性别、年龄和健康状况对一般西班牙人群进行 EORTC QLQ-C30 规范数据的分析。
Health Qual Life Outcomes. 2021 Aug 30;19(1):208. doi: 10.1186/s12955-021-01820-x.
4
Sex-differences in symptoms and functioning in >5000 cancer survivors: Results from the PROFILES registry.超过 5000 名癌症幸存者的症状和功能的性别差异:来自 PROFILES 登记处的结果。
Eur J Cancer. 2021 Oct;156:24-34. doi: 10.1016/j.ejca.2021.07.019. Epub 2021 Aug 16.
5
Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practice.真实世界临床实践中多发性骨髓瘤患者的报告疼痛严重程度和健康相关生活质量。
Cancer Rep (Hoboken). 2022 Jan;5(1):e1429. doi: 10.1002/cnr2.1429. Epub 2021 Jun 10.
6
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.辅助帕博利珠单抗对比安慰剂用于切除的 III 期黑色素瘤(EORTC 1325-MG/KEYNOTE-054):一项双盲、随机、对照、III 期临床试验的健康相关生活质量结果。
Lancet Oncol. 2021 May;22(5):655-664. doi: 10.1016/S1470-2045(21)00081-4. Epub 2021 Apr 12.
7
Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.过去和现在在癌症随机临床试验中使用患者报告结局测量的情况:系统评价。
Value Health. 2021 Apr;24(4):585-591. doi: 10.1016/j.jval.2020.11.004. Epub 2021 Feb 10.
8
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial.硼替佐米、沙利度胺和地塞米松联合或不联合达雷妥尤单抗用于符合移植条件的新诊断多发性骨髓瘤患者(CASSIOPEIA):一项随机、开放标签、3期试验的健康相关生活质量结果
Lancet Haematol. 2020 Dec;7(12):e874-e883. doi: 10.1016/S2352-3026(20)30356-2.
9
Health-related quality of life outcomes among breast cancer survivors.乳腺癌幸存者的健康相关生活质量结果。
Cancer. 2021 Apr 1;127(7):1114-1125. doi: 10.1002/cncr.33348. Epub 2020 Nov 25.
10
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial.PORTEC-3 随机试验:高危型子宫内膜癌辅助放化疗与单纯放疗后的长期毒性和健康相关生活质量
Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):975-986. doi: 10.1016/j.ijrobp.2020.10.030. Epub 2020 Oct 28.